Resonance Health (ASX:RHT) FCF Yield % : -2.00 (As of May. 12, 2024)

View and export this data going back to 1987. Start your Free Trial

What is Resonance Health FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Resonance Health's Trailing 12-Month Free Cash Flow is A$-0.69 Mil, and Market Cap is A$34.41 Mil. Therefore, Resonance Health's FCF Yield % for today is -2.00%.

The historical rank and industry rank for Resonance Health's FCF Yield % or its related term are showing as below:

ASX:RHT' s FCF Yield % Range Over the Past 10 Years
Min: -12.65 Med: -1.4 Max: 3.47
Current: -2

During the past 13 years, the highest FCF Yield % of Resonance Health was 3.47%. The lowest was -12.65%. And the median was -1.40%.

ASX:RHT's FCF Yield % is ranked worse than
61.56% of 679 companies
in the Healthcare Providers & Services industry
Industry Median: 0.51 vs ASX:RHT: -2.00

Resonance Health's FCF Margin % for the quarter that ended in Dec. 2023 was -12.77%.

Resonance Health FCF Yield % Historical Data

The historical data trend for Resonance Health's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resonance Health FCF Yield % Chart

Resonance Health Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Yield %

Get a 7-Day Free Trial

2.73

1.59

1.08

-8.36

-3.23

Resonance Health Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-3.18	-8.77	-2.57	-2.79	-2.98

Competitive Comparison of Resonance Health's FCF Yield %

For the Health Information Services subindustry, Resonance Health's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Resonance Health's FCF Yield % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Resonance Health's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Resonance Health's FCF Yield % falls into.

Resonance Health FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Resonance Health's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-0.625	/	19.3683
	=	-3.23%

Resonance Health's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.417	*	2	/	28.01358
	=	-2.98%

Resonance Health FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Resonance Health FCF Yield % Related Terms

Thank you for viewing the detailed overview of Resonance Health's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Resonance Health (ASX:RHT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Resonance Health Ltd (ASX:RHT) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

141 Burswood Road, Level 1, Burswood, WA, AUS, 6100

Website

https://www.resonancehealth.com

Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver, and HepaFat-Scan. The company's operating segment includes Services; Research and Development and Corporate. It generates maximum revenue from the Services segment. Geographically, it derives a majority of its revenue from North America and Europe-Middle-East-Africa (EMEA) and also has a presence in Asia/Pacific.

Resonance Health (ASX:RHT) Headlines

No Headlines